Multimodality imaging of adult rhabdomyosarcoma: The added value of hybrid imaging

14Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Rhabdomyosarcoma (RMS) represents more than 50% of paediatric soft tissue tumours. Conversely, it is extremely rare among adults, where it shows peculiar biological and clinical features that are still poorly investigated. RMS patients should be referred to a Sarcoma Centre, where the contribution of experienced radiologists plays a relevant role in the diagnostic assessment of the disease, including precise localisation, staging, image-guided biopsy, response evaluation after treatment and follow-up. Besides CT and MRI, hybrid imaging including positron emission tomography (PET)/CT and PET/MRI are giving an increasing contribution to provide functional insights about tumour biology and to improve the diagnostic accuracy of the imaging work-up. This review paper provides a revision of the pathology, clinical and radiological features of adult RMS, with a particular focus on the growing role of hybrid PET-based imaging.

Cite

CITATION STYLE

APA

Gennaro, N., Marrari, A., Renne, S. L., Cananzi, F. C. M., Quagliuolo, V. L., Brina, L. D., … Bertuzzi, A. F. (2020, August 1). Multimodality imaging of adult rhabdomyosarcoma: The added value of hybrid imaging. British Journal of Radiology. British Institute of Radiology. https://doi.org/10.1259/bjr.20200250

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free